Abbratech
25 Business Park Drive
Suite C
Branford, CT 06405
Phone: 203-444-3503
General Information:
AbbraTech is a biotechnology company focused on building an internal pipeline of a limited number of novel antibody therapeutics targeting difficult disease biology. Founded in 2020 in Branford, Connecticut, the company applies advanced antibody discovery technologies to develop medicines for diseases with significant unmet medical need.
AbbraTech selectively advances therapeutic programs enabled by the antibody discovery platforms developed by its affiliated platform company, Precision BioTools. By focusing on a limited number of high-value targets, AbbraTech aims to translate these technologies into differentiated therapeutic candidates.
The company’s programs leverage the EPIVOLVE platform to generate antibodies capable of recognizing specific exposed regions of target proteins that are not accessible with conventional antibody discovery methods. This approach enables AbbraTech to pursue disease targets that have historically been difficult to drug.
Research Activities
AbbraTech’s research efforts focus on advancing a small number of high-impact antibody programs. Using the EPIVOLVE platform and related technologies, the company is able to generate highly targeted antibodies designed to engage challenging epitopes on disease-associated proteins. Through focused development of these proprietary therapeutic assets, AbbraTech aims to translate breakthrough antibody discovery capabilities into next-generation medicines.
< RETURN TO MEMBER DIRECTORY